← Eichor
Study identifier: NCT06569706 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Feasibility and Acceptability of Endoscopic Mastectomy in Patients With Breast Cancer

Condition: Breast Cancer  ·  Sponsor: University Hospital, Montpellier

PhaseNA
Planned participants20
Who can joinFemale, 20 Years to 75 Years
Healthy volunteersNo

About this study

Nipple -Sparing Mastectomy (NSM), with immediate breast reconstruction (IBR) can be offered to patients requiring mastectomy when the lesion is more than 2cm from the nipple. Endoscopic mastectomy is a technical alternative for small-volume breasts (cup sizes A, B, C), offering a NSM with IBR, but also concealing the scar on the axillary line. It can be performed with traditional laparoscopic equipment, making this technique much more accessible and less costly than robotic mastectomy. It uses a single-port device that is significantly less costly than robotic equipment. Feasibility and safety studies remain limited to the Asian continent, and it would undoubtedly be beneficial to initiate research in Europe to add this new technical option to our surgical arsenal. This study project aims to explore the feasibility and safety of endoscopic nipple-sparing mastectomy for breast cancer indications in a French center.

This description comes directly from the study's public registry record.

Talk to the study team

Gauthier Rathat, MD  ·  467336532  ·  g-rathat@chu-montpellier.fr

Always discuss trial participation with your own doctor first.

Locations (1)

UhmontpellierMontpellier, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06569706